Supernus Pharmaceuticals, Inc. - Common Stock (NQ:SUPN)
Price and Volume
Detailed Quote| Volume | 563,504 |
| Open | 50.75 |
| Bid (Size) | 36.63 (100) |
| Ask (Size) | 56.00 (100) |
| Prev. Close | 50.86 |
| Today's Range | 49.63 - 51.23 |
| 52wk Range | 29.16 - 57.65 |
| Shares Outstanding | 53,145,884 |
| Dividend Yield | N/A |
Top News
More News
Supernus Pharmaceuticals (SUPN) To Report Earnings Tomorrow: Here Is What To Expect
February 22, 2026
Via StockStory
Topics
Artificial Intelligence
Performance
| YTD |
+2.5%
|
+2.5%
|
| 1 Month |
+5.1%
|
+5.1%
|
| 3 Month |
+12.3%
|
+12.3%
|
| 6 Month |
+14.1%
|
+14.1%
|
| 1 Year |
+55.1%
|
+55.1%
|
More News
Read More
3 Reasons to Avoid SUPN and 1 Stock to Buy Instead
February 16, 2026
Via StockStory
Why Late-Stage CNS, Oncology Assets Are Becoming the Hottest Targets in Biotech M&A
February 17, 2026
From BioMedWire
Via GlobeNewswire
1 Cash-Heavy Stock on Our Buy List and 2 We Brush Off
February 08, 2026
Via StockStory
1 Healthcare Stock to Consider Right Now and 2 We Brush Off
January 28, 2026
Via StockStory
Topics
Stocks
2 Cash-Producing Stocks to Consider Right Now and 1 Facing Headwinds
January 25, 2026
Via StockStory
3 Unprofitable Stocks We Steer Clear Of
January 21, 2026
Via StockStory
3 Low-Volatility Stocks We’re Skeptical Of
December 31, 2025
Via StockStory
3 of Wall Street’s Favorite Stocks That Concern Us
December 22, 2025
Via StockStory
1 Cash-Heavy Stock for Long-Term Investors and 2 We Turn Down
December 14, 2025
Via StockStory
3 Stocks Under $50 That Concern Us
December 11, 2025
Via StockStory
3 Unprofitable Stocks We Find Risky
December 03, 2025
Via StockStory
1 Healthcare Stock Worth Your Attention and 2 Facing Headwinds
November 23, 2025
Via StockStory
Topics
Stocks
This Fund Sold $30 Million in PTC Therapeutics Shares Amid a 93% Rally: Here’s Why ↗
November 18, 2025
Via The Motley Fool
Topics
Regulatory Compliance
Via The Motley Fool
3 Russell 2000 Stocks Walking a Fine Line
November 13, 2025
Via StockStory
Frequently Asked Questions
Is Supernus Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Supernus Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Supernus Pharmaceuticals, Inc. - Common Stock trade on?
Supernus Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Supernus Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Supernus Pharmaceuticals, Inc. - Common Stock is SUPN on the Nasdaq Stock Market
What is the current price of Supernus Pharmaceuticals, Inc. - Common Stock?
The current price of Supernus Pharmaceuticals, Inc. - Common Stock is 50.69
When was Supernus Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Supernus Pharmaceuticals, Inc. - Common Stock was at 02/23/26 04:00 PM ET
What is the market capitalization of Supernus Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Supernus Pharmaceuticals, Inc. - Common Stock is 2.69B
How many shares of Supernus Pharmaceuticals, Inc. - Common Stock are outstanding?
Supernus Pharmaceuticals, Inc. - Common Stock has 3B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>